Article Text

Download PDFPDF
Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression

Statistics from Altmetric.com

Footnotes

  • Contributors FM and JT reviewed the literature and wrote the commentary.

  • Funding JT is supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57 P18), European Union H2020 and Cellex Foundation.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles